HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 1.7% of their position (20K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.27M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/13/2026ACC: 0001104659-26-015453
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-20K
Net shares
Net seller
$1.27M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−11.49K
Price / share
$62.96
Trade value
$723.66K
% of position
1.0%
2/11/2026
1.19M→1.18M
Common Stock
Direct
Shares
−7.55K
Price / share
$63.73
Trade value
$481.23K
% of position
0.6%
2/11/2026
1.18M→1.17M
Common Stock
Direct
Shares
−955.00
Price / share
$64.99
Trade value
$62.07K
% of position
0.1%
2/11/2026
1.17M→1.17M
Total
Net shares
−20K
Net value
-$1.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | S · Sale | −11.49K | $62.96 | $723.66K | 1.0% | 1.19M | 1.18M |
| Common Stock Direct | 2/11/2026 | S · Sale | −7.55K | $63.73 | $481.23K | 0.6% | 1.18M | 1.17M |
| Common Stock Direct | 2/11/2026 | S · Sale | −955.00 | $64.99 | $62.07K | 0.1% | 1.17M | 1.17M |
| Total | −20K | -$1.27M | ||||||
Derivative Transactions0
No derivative transactions reported